Head-to-head for moms
CoreAge Rx vs Invyncible
CoreAge Rx and Invyncible both offer GLP-1 telehealth to mothers, but they make different trade-offs on family-budget value, clinical oversight, price and access. Here they are side-by-side on the Editors' Rating — our six-factor rubric for mothers.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.
Visit CoreAge RxInvyncible
Ranked #128 · Grade C
Best for: A mother who wants the option to start compounded and later switch to a brand-name pen without changing providers, and who values a disclosed corporate parent and address.
Visit InvyncibleThe verdict
CoreAge Rx edges out Invyncible on the Editors' Rating, 94 to 46 (A vs C). Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.
Invyncible is still a genuine option — invyncible pairs cheaper compounded semaglutide ($192.50/mo) or tirzepatide ($210/mo) with the option to move to an FDA-approved Wegovy or Zepbound pen on the same account — a real dual-modality option most competitors don't offer — but availability by state isn't disclosed until intake. Weigh the six factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Invyncible |
|---|---|---|
| Editors' Rating | 94/100 · A | 46/100 · C |
| Overall rank | #1 | #128 |
| Semaglutide | $99/mo | $192.50/mo |
| Tirzepatide | $149/mo | $210/mo |
| Coverage | All 50 states | Not publicly disclosed; confirmed during intake |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat all-in price that doesn't step up after month one — the number you sign for is the number at the full dose
- Both compounded semaglutide and tirzepatide on a single account, so a molecule switch never resets the budget
- Licensed in all 50 states — care survives a move, a deployment, or a summer at the grandparents'
The caveats
- Not the rock-bottom sticker price — a bare teaser tier elsewhere can look cheaper for exactly one month
- Compounded only; no FDA-approved brand Wegovy or Zepbound if that is what you and your clinician want
- A general metabolic program, not a dedicated women's or maternal-health clinic
Invyncible
Ranked #128 · Grade C
What we like
- Names its corporate parent and a physical address rather than hiding behind a trade name
- LegitScript-verified
- Both compounded programs and FDA-approved brand-name Wegovy/Zepbound sold on one account
The caveats
- No state-availability list — confirmed only during intake
- Every price is displayed as a permanent 'sale' against a higher reference figure that never appears to actually apply
- Brand-name pricing ($1,540–$1,750/mo) still runs well above most insurance-backed options
We may earn a referral fee if you sign up through a link on this page, at no extra cost to you — and it has no bearing on which provider scores higher. Pricing, states and verification reflect each provider's public disclosures at last review; the Editors' Rating is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Invyncible against other providers we review for mothers.
Or browse the full comparison hub.